Masimo Archives - Page 7 of 7 - Medical Design Sourcing

FDA clears Masimo respiration sensor

Masimo (NSDQ:MASI) announced today that its Centroid wireless orientation, activity and respiration rate sensor received FDA clearance.

Centroid is a wearable sensor designed to monitor patient position in an effort to avoid preventable pressure ulcers, while also alerting clinicians to sudden movements, such as fall-like events. The device also detects chest movements to continuously provide respiration rate, offering data that could inform care decisions.

When paired with the Root patient monitoring and connectivity platform via Bluetooth, Centroid helps to track posture, orientation and activity. Data from these trackings can be displayed on Root in multiple ways, giving clinicians options in assessing protocols regarding tissue stress and patient needs.

Centroid, which can identify if a patient is lying down, standing, sitting upright, walking, or may have fallen, can also measure respiration accurately to within three respirations per minute (RPM) i…

Masimo launches monitoring for reopening economy

Masimo recently launched its SafetyNet-Open that is designed to businesses, governments and schools manage employee and student health and safety during the COVID-19 pandemic.

The remote patient monitoring solution helps coordinate the continuous monitoring of people through sensors and an app. Its centralized dashboard helps organizations understand patterns that could support contact tracing. The components of the system provide integrated and secure monitoring that organizations can use to identify when additional actions may be needed.

“As the COVID-19 pandemic continues, businesses, governments, and schools around the world have to make difficult risk analysis decisions that balance the health and safety of their constituents with their communities’ needs. We are not in the position to suggest when it’s safe to reopen, but we are in the unique position to help those who are going to open, to open as safely as possible—and hopefully help them stay open,R…

Philips patient monitors to add more Masimo technology

Masimo (NSDQ:MASI) and Royal Philips (NYSE:PHG) announced today that Philips will integrate additional Masimo measurement technologies into certain IntelliVue MX-series monitors to help clinicians assess cerebral oximetry and ventilation status.

Masimo noninvasive measurements, such as SET measure-through motion and Low Perfusion pulse oximetry and advanced rainbow SET Pulse CO-Oximetry parameters like noninvasive hemoglobin (SpHb), have long been available on a wide range of Philips multi-parameter monitors.

In 2016, Masimo and Philips entered into a multi-year business partnership with Philips agreeing to integrate Masimo’s SedLine brain function monitoring, O3 regional oximetry and Nomoline capnography tech into certain Philips IntelliVue monitors.

The latest agreement will add Masimo’s NomoLine and O3 measurements to Philips patient monitors to provide capnography and regional cerebral oximetry.

NomoLine capnography and O3 regional oxi…